Joseph B. Swiader, Director at BioRestorative Therapies, Inc. (BRTX), bought 100,000 shares at $0.25 ($25K) on 2014-06-30, disclosed to the SEC on 2014-07-02.
Open-market purchase of $25k BRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.